Genentech on Forbes' Platinum List
By Amanda Janis/Business Writer
Biotherapuetic developer and manufacturer Genentech was among nine pharmaceutical and biotechnology companies that made this year's Forbes Platinum 400 list, released by the business and financial media group this week.
Genentech - which is significantly expanding its Vacaville facilities - was ranked 153 out of 400 companies, based upon factors including a five-year total return of 22.6 percent, 42.8 percent sales growth in the last 12 months, and more than $6 million in sales and a net income in excess of $1 billion through November 2005, according to Forbes.
Genentech was the second-highest ranked company of its kind, coming in behind Gilead Sciences, which makes therapeutics for life-threatening diseases including HIV and influenza. This is the third year Genentech has made the Forbes list.
The magazine's annual list, which is also referred to as the America's Best Big Companies list, has - for six out of seven years - outperformed the stock market in the 12 months following its release, according to Forbes.
"The Platinum 400 had its best 12-month run in 2003, when it gained an average 26 percent vs. 13 percent from the S&P 500 and 10 percent for the Dow Jones Industrial Average," wrote Forbes' Brian Zajac in an introductory article published with the list of companies and statistics.
According to Zajac, selection criteria for companies included revenue of at least $1 billion, stock prices at or above $5 per share, and having been public entities for at least two years. Forbes then ranked companies against industry counterparts over
the past five years, as well as over the past 12 months.
In addition to Genentech and Gilead Sciences, the drug and biotech companies that made the Forbes Platinum 400 list were Barr Pharmaceuticals, Johnson & Johnson, Amgen, Allergan, Abbott Laboratories, Invitrogen and King Pharmaceuticals.
Amanda Janis can be reached email@example.com.
Wednesday, December 28, 2005
- ► 2007 (799)
- ► 2006 (662)
- Report: Sacramento workers earn more than national...
- Full Accreditation Awarded
- Phase 1 of Vallejo Project is Residential
- Solano County Unemployment Drops
- Genentech on Forbes' Platinum List
- Roadways in the Area 'Very Good'
- Downtown Renaissance Continues
- Solano EDC Meeting Set
- Rio Vista Transit System Offers New Fares, Routes
- Builder Announced in Vallejo Project
- County's Jobless Rate Shows Strength
- Sister cities
- Coffee Tree Sips Long Gone, Nut Tree Sibling Falls...
- Westfield Solano Mall Considers Expansion
- Oakland Port OKs W. Sac Deal
- Study: Jobs in Greater Sacramento up at least 2 pe...
- Brooks Pedder Becomes Chairman of Solano EDC
- Commissioners to consider Dixon development projec...
- Saca unveils plan for third high rise condo tower
- Top Sacramento brokerage sees sturdy '06
- Solano County Unemployment Falls in November
- A Triumph at the Sutter Solano Center
- Poll Encouraging for Tax Advocates
- More Solano County residents own their own home th...
- Solano Job Numbers Keep Growing
- Flashy Annual Report Trumpets County's Successes
- Seeking to Mix it Up
- Fairfield's On Its Way To "Great Things"
- Officials Talk Trains with Solano Residents
- Suisun City Courts Developers
- Capitols on Roll With Record Rider Ship
- Spirit of Community Involvement Honored at Awards
- 2006 Could be Big for Rio Vista
- Nut Tree's New Era Begins
- Travis to Reopen Main Gate
- Suisun Lighthouse Should be Finished by July
- County could move ahead with post office purchase
- Outlook good for Bay Area economy
- Dump Expansion Plans on Hold
- Mission Solano Breaks Ground for New Shelter
- Suisun City's Growing Business
- New Center Aids Area's Cancer Care
- Fairfield Set for Shelter's Construction
- ▼ December (43)
- ► 2004 (125)